ODT

25-NSE - Odonate Therapeutics, Inc. (0001717452) (Subject)

Gainers Bone Biologics Corporation (NASDAQ:BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ:ZNGA) rose 40.7% to settle at $8.44 after the company announced it will be acquired by Take-Two Interactive Software in a cash and stock transaction valued at $9.86 per Zynga share, representing a total enterprise value of approximately $12.7 billion. Molecular Partners AG (NASDAQ:MOLN) surged 30.5% to settle at $21.50 after the company, and Novartis, reported topline data from the Phase 2 study for ensovibep, a DARPin antiviral therapeutic for COVID-19. Reliance Global Group, Inc. (NASDAQ:RELI) climbed 28.9% to close at $7.86. Reliance Global Group, last month, announc

Gainers Hour Loop, Inc. (NASDAQ:HOUR) shares jumped 99.8% to $7.99 after the company priced its IPO at $4 per share. China HGS Real Estate Inc. (NASDAQ:HGSH) shares surged 57.5% to close at $3.48 on Friday. Traders may be viewing this stock as a play on a Friday deal by Papa John's to expand its presence in China by 1,350 stores. The Papa John's press release did not specifically mention a real estate company it would be working with for the expansion. ATA Creativity Global (NASDAQ:AACG) gained 33.3% to settle at $2.64. Marin Software Incorporated (NASDAQ:MRIN) shares jumped 31.3% to close at $4.53 on Friday after the company announced an integration with Amazon Ads' demand-side platfo

  Gainers Absci (NASDAQ:ABSI) stock increased by 28.2% to $7.87 during Friday's regular session. As of 12:30 EST, Absci's stock is trading at a volume of 38.6 million, which is 15366.1% of its average full-day volume over the last 100 days. The company's market cap stands at $728.6 million. Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 15.8% to $2.02. Trading volume for Quoin Pharmaceuticals's stock is 41.2 million as of 12:30 EST. This is 3934.9% of its average full-day volume over the last 100 days. The company's market cap stands at $16.8 million. Anixa Biosciences (NASDAQ:ANIX) shares increased by 15.06% to $3.36. Trading volume for this security as of 12:30 EST is 213

  Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap basis to set a new 52-week low. Reshape Lifesciences (NASDAQ:RSLS) was the smallest firm on a market cap basis to set a new 52-week low. Aligos Therapeutics (NASDAQ:ALGS)'s stock moved significantly downwards, trading down 46.75% to reach a new 52-week low. Athenex (NASDAQ:ATNX) shares were the most resilient of the group, as shares actually moved up 0.0% in response to hitting its 52-week low. Stocks that set new 52-week lows during the first half-hour of trading on Friday are as follows: Humana (NYSE:HUM) stock hi

Odonate Therapeutics, Inc. (NASDAQ:ODT) today announced that on January 6, 2022 it received written notice from The Nasdaq Stock Market LLC ("Nasdaq") notifying Odonate that Nasdaq believes that Odonate is a "public shell" pursuant to Listing Rule 5101, and that the continued listing of its securities is no longer warranted. Odonate will not appeal this determination. Therefore, Odonate expects the trading of its common stock on The Nasdaq Stock Market to be suspended at the opening of business on January 18, 2022, and that Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission (the "SEC"), which will remove Odonate's securities from listing and registration on The N

8-K - Odonate Therapeutics, Inc. (0001717452) (Filer)

Odonate Therapeutics, Inc. (NASDAQ:ODT) today announced that on January 6, 2022 it received written notice from The Nasdaq Stock Market LLC ("Nasdaq") notifying Odonate that Nasdaq believes that Odonate is a "public shell" pursuant to Listing Rule 5101, and that the continued listing of its securities is no longer warranted. Odonate will not appeal this determination. Therefore, Odonate expects the trading of its common stock on The Nasdaq Stock Market to be suspended at the opening of business on January 18, 2022, and that Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission (the "SEC"), which will remove Odonate's securities from listing and registration on The

    On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows And Highs: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this morning. The smallest company by market cap to hit a new 52-week low was Reshape Lifesciences (NASDAQ:RSLS). Aligos Therapeutics (NASDAQ:ALGS) saw the largest move of the companies, as shares plummetted 46.75% to hit a new 52-week low. Vimeo (NASDAQ:VMEO) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low. The following stocks created new 52-week lows as of 10am on Thursday: Rivian Automotive (NASDAQ:RIVN) stock achieved a new 52-week low on Thursday morning, hitting $75

4 - Odonate Therapeutics, Inc. (0001717452) (Issuer)

SC 13G/A - Odonate Therapeutics, Inc. (0001717452) (Subject)

Gainers Aptinyx (NASDAQ:APTX) shares rose 4.72% to $2.66 during Wednesday's after-market session. Trading volume for this security closed at 80.2K, accounting for 49.36% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $180.1 million. iSpecimen (NASDAQ:ISPC) shares rose 4.24% to $14.75. The market value of their outstanding shares is at $128.5 million. Reshape Lifesciences (NASDAQ:RSLS) stock rose 3.96% to $2.1. The company's market cap stands at $7.3 million. Bluejay Diagnostics (NASDAQ:BJDX) stock rose 3.86% to $2.69. The market value of their outstanding shares is at $34.1 million. Odonate Therapeutics (NASDAQ:ODT) stock rose 3

SC 13D/A - Odonate Therapeutics, Inc. (0001717452) (Subject)

4 - Odonate Therapeutics, Inc. (0001717452) (Issuer)

SC 13D/A - Odonate Therapeutics, Inc. (0001717452) (Subject)

4 - Odonate Therapeutics, Inc. (0001717452) (Issuer)

4 - Odonate Therapeutics, Inc. (0001717452) (Issuer)

SC 13D/A - Odonate Therapeutics, Inc. (0001717452) (Subject)

4 - Odonate Therapeutics, Inc. (0001717452) (Issuer)

8-K - Odonate Therapeutics, Inc. (0001717452) (Filer)

SC 13G/A - Odonate Therapeutics, Inc. (0001717452) (Subject)

3 - Odonate Therapeutics, Inc. (0001717452) (Issuer)

Odonate Therapeutics, Inc. (NASDAQ:ODT) today announced that it will commence a share repurchase plan for up to 20 million shares in order to return capital to stockholders. This action is in connection with the Company's previously announced decision to discontinue the development of tesetaxel. Repurchases may be made from time to time at the Company's discretion. The plan has no time limit and can be discontinued at any time. There can be no assurance as to the timing or number of shares of any repurchases. As of September 30, 2021, as reported in its recently filed Form 10-Q, the Company had total stockholders' equity of $71.4 million, or $1.85 per share, based on 38.5 million shares ou

Odonate Therapeutics, Inc. (NASDAQ:ODT) today announced financial results for the three and nine months ended September 30, 2021. As of September 30, 2021, Odonate had $95.0 million in cash compared to $157.3 million as of December 31, 2020. Odonate's cash used in operating activities for the three and nine months ended September 30, 2021 was $15.1 million and $63.0 million, respectively. Odonate's net loss for the three and nine months ended September 30, 2021 was $14.0 million and $69.8 million, or $0.37 and $1.85 per share, respectively, compared to $30.5 million and $94.1 million, or $0.93 and $3.00 per share, respectively, for the same periods in 2020. About Odonate Therapeutics, In